Thank your interest in our research study on Cutaneous T-Cell Lymphoma (CTCL).

Below you will find some more information that may help answer some of your questions regarding this research study.

In order to be eligible subjects must:

• Have Cutaneous T-Cell Lymphoma (CTCL) in stage IB or higher
• Have a life expectancy greater than three months
• Be able to swallow capsules
• Agree to practice effective contraception during the entire study and if you are female, you cannot be pregnant or breastfeeding
• Be 18 years old or older and if you are female, you cannot be pregnant or breastfeeding
• Cannot have a known history of HIV, active Hepatitis B or C infection, have any ongoing or active infections, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia or psychiatric illness

Additional inclusion and exclusion criteria will be discussed with you during the screening visit.

At the screening visit, we will have you read the informed consent and meet with the research staff. You will be given the opportunity to ask questions and time to consider whether or not you would like to participate in the study. If you decide to participate in the study, the study-screening visit will be performed.

If you have any questions or would like to schedule a screening visit, please call us at 617-726-5066 or e-mail us at harvardskinstudies@partners.org.

Thank you and we look forward to meeting with you.

Clinical Unit for Research Trials in Skin (CURTIS)
Massachusetts General and Brigham & Women’s Hospitals